The interaction of PD-1+ NK with PD-L1 on tumor cells leading to a decrease in NK cell response and a more aggressive tumor in vivo, has also been confirmed in many other types of cancers, including digestive cancer, melanomas, multiple myelomas, and lymphomas17,44–46. This evidence concerns the gene CD274 and neoplasm.